{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:12:12Z","timestamp":1758478332580},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"PROCRIN","award":["R2-024"],"award-info":[{"award-number":["R2-024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13023-017-0667-4","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T08:33:59Z","timestamp":1497947639000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung\u2019s disease in newborns \u2013 a nationwide cohort study"],"prefix":"10.1186","volume":"12","author":[{"given":"Sebastian Werngreen","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perniller M\u00f8ller","family":"Ljungdalh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente Mertz","family":"N\u00f8rg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Qvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"key":"667_CR1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2007.07.036","volume":"198","author":"SE Andrade","year":"2008","unstructured":"Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198:194. e1-5","journal-title":"Am J Obstet Gynecol"},{"key":"667_CR2","doi-asserted-by":"crossref","first-page":"e63034","DOI":"10.1371\/journal.pone.0063034","volume":"8","author":"E Jimenez-Solem","year":"2013","unstructured":"Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Andersen NL, Torp-Pedersen C, et al. Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study. PLoS One. 2013;8:e63034.","journal-title":"PLoS One"},{"key":"667_CR3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2007.03048.x","volume":"65","author":"MK Bakker","year":"2008","unstructured":"Bakker MK, K\u00f6lling P, van den Berg PB, de Walle HEK, de Jong van den Berg LTW. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol. 2008;65:600\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"667_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bdra.20773","volume":"91","author":"L Colvin","year":"2011","unstructured":"Colvin L, Slack-Smith L, Stanley FJ, Bower C. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birt Defects Res A Clin Mol Teratol. 2011;91:142\u201352.","journal-title":"Birt Defects Res A Clin Mol Teratol."},{"key":"667_CR5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","volume":"63","author":"TF Oberlander","year":"2006","unstructured":"Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63:898\u2013906.","journal-title":"Arch Gen Psychiatry"},{"key":"667_CR6","doi-asserted-by":"publisher","unstructured":"Knudsen TM, Hansen AV, Garne E, Andersen A-MN. Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy \u2013 an epidemiological study using validated EUROCAT data. BMC Pregnancy Childbirth. 2014;14 doi: 10.1186\/1471-2393-14-333 .","DOI":"10.1186\/1471-2393-14-333"},{"key":"667_CR7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10654-015-0065-y","volume":"30","author":"A Wemakor","year":"2015","unstructured":"Wemakor A, Casson K, Garne E, Bakker M, Addor M-C, Arriola L, et al. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Eur J Epidemiol. 2015;30:1187\u201398.","journal-title":"Eur J Epidemiol"},{"key":"667_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/AOG.0b013e318220edcc","volume":"118","author":"H Malm","year":"2011","unstructured":"Malm H, Artama M, Gissler M, Ritvanen A. Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol. 2011;118:111\u201320.","journal-title":"Obstet Gynecol"},{"key":"667_CR9","doi-asserted-by":"crossref","unstructured":"Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA. Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports. BMJ. \u00a02015;8;351:h3190.","DOI":"10.1136\/bmj.h3190"},{"key":"667_CR10","doi-asserted-by":"crossref","first-page":"e001148","DOI":"10.1136\/bmjopen-2012-001148","volume":"2","author":"E Jimenez-Solem","year":"2012","unstructured":"Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Jensen JK, Afzal S, et al. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open. 2012;2:e001148.","journal-title":"BMJ Open"},{"key":"667_CR11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/FTD.0b013e31826d07ea","volume":"34","author":"H Malm","year":"2012","unstructured":"Malm H. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome. Ther Drug Monit. 2012;34:607\u201314.","journal-title":"Ther Drug Monit"},{"key":"667_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3810\/pgm.2010.07.2175","volume":"122","author":"M Tuccori","year":"2010","unstructured":"Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, et al. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update. Postgrad Med. 2010;122:49\u201365.","journal-title":"Postgrad Med"},{"key":"667_CR13","doi-asserted-by":"crossref","unstructured":"Margulis AV, Abou-Ali A, Strazzeri MM, Ding Y, Kuyateh F, Frimpong EY, et al. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD: SSRIS AND CARDIAC MALFORMATIONS. Pharmacoepidemiol Drug Saf. 2013;:n\/a-n\/a.","DOI":"10.1002\/pds.3462"},{"key":"667_CR14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bdra.20327","volume":"79","author":"BAJ K\u00e4ll\u00e9n","year":"2007","unstructured":"K\u00e4ll\u00e9n BAJ, Otterblad OP. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birt Defects Res A Clin Mol Teratol. 2007;79:301\u20138.","journal-title":"Birt Defects Res A Clin Mol Teratol."},{"key":"667_CR15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/JCP.0b013e3182490eaf","volume":"32","author":"H Nordeng","year":"2012","unstructured":"Nordeng H, van Gelder MMHJ, Spigset O, Koren G, Einarson A, Eberhard-Gran M. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian mother and child cohort study. J Clin Psychopharmacol. 2012;32:186\u201394.","journal-title":"J Clin Psychopharmacol"},{"key":"667_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0306-4522(98)00281-4","volume":"89","author":"SR Hansson","year":"1999","unstructured":"Hansson SR, Mezey E, Hoffman BJ. Serotonin transporter messenger RNA expression in neural crest-derived structures and sensory pathways of the developing rat embryo. Neuroscience. 1999;89:243\u201365.","journal-title":"Neuroscience"},{"key":"667_CR17","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1523\/JNEUROSCI.6684-10.2011","volume":"31","author":"Z Li","year":"2011","unstructured":"Li Z, Chalazonitis A, Huang Y-Y, Mann JJ, Margolis KG, Yang QM, et al. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development\/survival of enteric Dopaminergic neurons. J Neurosci. 2011;31:8998\u20139009.","journal-title":"J Neurosci"},{"key":"667_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MED.0b013e32835bc703","volume":"20","author":"MD Gershon","year":"2013","unstructured":"Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20:14\u201321.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"667_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2013.03.001","volume":"162","author":"NE Butler Tjaden","year":"2013","unstructured":"Butler Tjaden NE, Trainor PA. The developmental etiology and pathogenesis of Hirschsprung disease. Transl Res. 2013;162:1\u201315.","journal-title":"Transl Res"},{"key":"667_CR20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/j.sempedsurg.2012.07.008","volume":"21","author":"RJ Rintala","year":"2012","unstructured":"Rintala RJ, Pakarinen MP. Long-term outcomes of Hirschsprung\u2019s disease. Semin Pediatr Surg. 2012;21:336\u201343.","journal-title":"Semin Pediatr Surg"},{"key":"667_CR21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/bdra.23016","volume":"94","author":"KE Best","year":"2012","unstructured":"Best KE, Glinianaia SV, Bythell M, Rankin J. Hirschsprung\u2019s disease in the north of England: prevalence, associated anomalies, and survival. Birt Defects Res A Clin Mol Teratol. 2012;94:477\u201380.","journal-title":"Birt Defects Res A Clin Mol Teratol."},{"key":"667_CR22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/bdra.23269","volume":"100","author":"KE Best","year":"2014","unstructured":"Best KE, Addor M-C, Arriola L, Balku E, Barisic I, Bianchi F, et al. Hirschsprung\u2019s disease prevalence in Europe: a register based study: Hirschsprung\u2019s disease in Europe. Birt Defects Res A Clin Mol Teratol. 2014;100:695\u2013702.","journal-title":"Birt Defects Res A Clin Mol Teratol."},{"key":"667_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/cge.12032","volume":"83","author":"K-F Bergeron","year":"2013","unstructured":"Bergeron K-F, Silversides D, Pilon N. The developmental genetics of Hirschsprung\u2019s disease: developmental genetics of Hirschsprung\u2019s disease. Clin Genet. 2013;83:15\u201322.","journal-title":"Clin Genet"},{"issue":"7 Suppl","key":"667_CR24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 Suppl):30\u20133.","journal-title":"Scand J Public Health."},{"key":"667_CR25","first-page":"320","volume":"45","author":"LB Knudsen","year":"1998","unstructured":"Knudsen LB, Olsen J. The Danish medical birth Registry. Dan Med Bull. 1998;45:320\u20133.","journal-title":"Dan Med Bull"},{"issue":"7 Suppl","key":"667_CR26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"H Wallach Kildemoes","year":"2011","unstructured":"Wallach Kildemoes H, Toft Sorensen H, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38\u201341.","journal-title":"Scand J Public Health"},{"key":"667_CR27","first-page":"441","volume":"53","author":"CB Pedersen","year":"2006","unstructured":"Pedersen CB, G\u00f8tzsche H, M\u00f8ller JO, Mortensen PB. The Danish civil registration system. A cohort of eight million persons. Dan Med Bull. 2006;53:441\u20139.","journal-title":"Dan Med Bull"},{"key":"667_CR28","volume-title":"International statistical classification of diseases and health related problems (the) ICD-10","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. International statistical classification of diseases and health related problems (the) ICD-10. 2004."},{"key":"667_CR29","volume-title":"Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs)","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs). 2004."},{"key":"667_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/CLEP.S37587","volume":"4","author":"SA Johannesdottir","year":"2012","unstructured":"Johannesdottir SA, Horv\u00e1th-Puh\u00f3 E, Ehrenstein V, Schmidt M, Pedersen L, S\u00f8rensen HT. Existing data sources for clinical epidemiology: the Danish National Database of reimbursed prescriptions. Clin Epidemiol. 2012;4:303\u201313.","journal-title":"Clin Epidemiol"},{"key":"667_CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1096-9926(199907)60:1<33::AID-TERA9>3.0.CO;2-X","volume":"60","author":"LT Jong van den Berg De","year":"1999","unstructured":"De Jong van den Berg LT, Feenstra N, Sorensen HT, Cornel MC. Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP group. Europen medicine and pregnancy group. Teratology. 1999;60:33\u20136.","journal-title":"Teratology"},{"key":"667_CR32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/bdra.22888","volume":"94","author":"P Sarangarm","year":"2012","unstructured":"Sarangarm P, Young B, Rayburn W, Jaiswal P, Dodd M, Phelan S, et al. Agreement between self-report and prescription data in medical records for pregnant women. Birt Defects Res A Clin Mol Teratol. 2012;94:153\u201361.","journal-title":"Birt Defects Res A Clin Mol Teratol"},{"key":"667_CR33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12884-015-0745-3","volume":"15","author":"FE Pisa","year":"2015","unstructured":"Pisa FE, Casetta A, Clagnan E, Michelesio E, Vecchi Brumatti L, Barbone F. Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort. BMC Pregnancy Childbirth. 2015;15:310.","journal-title":"BMC Pregnancy Childbirth"},{"key":"667_CR34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00001648-200109000-00006","volume":"12","author":"C Olesen","year":"2001","unstructured":"Olesen C, S\u00f8ndergaard C, Thrane N, Nielsen GL, de Jong-van den Berg L, Olsen J, et al. Do pregnant women report use of dispensed medications? Epidemiol Camb Mass. 2001;12:497\u2013501.","journal-title":"Epidemiol Camb Mass"},{"key":"667_CR35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00228-011-1021-8","volume":"67","author":"B K\u00e4ll\u00e9n","year":"2011","unstructured":"K\u00e4ll\u00e9n B, Nilsson E, Olausson PO. Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records. Eur J Clin Pharmacol. 2011;67:839\u201345.","journal-title":"Eur J Clin Pharmacol"},{"key":"667_CR36","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00787-014-0582-3","volume":"23","author":"CS Waters","year":"2014","unstructured":"Waters CS, Hay DF, Simmonds JR, van Goozen SHM. Antenatal depression and children\u2019s developmental outcomes: potential mechanisms and treatment options. Eur Child Adolesc Psychiatry. 2014;23:957\u201371.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"667_CR37","doi-asserted-by":"publisher","unstructured":"Olivier JDA, \u00c5kerud H, Kaihola H, Pawluski JL, Skalkidou A, H\u00f6gberg U, et al. The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Front Cell Neurosci. 2013;7 doi: 10.3389\/fncel.2013.00073 .","DOI":"10.3389\/fncel.2013.00073"},{"key":"667_CR38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.genhosppsych.2009.04.003","volume":"31","author":"KA Yonkers","year":"2009","unstructured":"Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009;31:403\u201313.","journal-title":"Gen Hosp Psychiatry"},{"key":"667_CR39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/npp.2015.266","volume":"41","author":"JW Smoller","year":"2016","unstructured":"Smoller JW. The genetics of stress-related disorders: PTSD, depression, and anxiety disorders. Neuropsychopharmacology. 2016;41:297\u2013319.","journal-title":"Neuropsychopharmacology"},{"key":"667_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2007.053959","volume":"45","author":"J Amiel","year":"2007","unstructured":"Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, Borrego S, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2007;45:1\u201314.","journal-title":"J Med Genet"},{"issue":"417(2)","key":"667_CR41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ydbio.2016.06.017","volume":"15","author":"A Torroglosa","year":"2016","unstructured":"Torroglosa A, Alves MM, Fern\u00e1ndez RM, Anti\u00f1olo G, Hofstra RM, Borrego S. Epigenetics in ENS development and Hirschsprung disease. Dev Biol. 2016;15(417(2)):209\u201316.","journal-title":"Dev Biol"},{"key":"667_CR42","doi-asserted-by":"crossref","first-page":"e12201","DOI":"10.1371\/journal.pone.0012201","volume":"5","author":"AM Devlin","year":"2010","unstructured":"Devlin AM, Brain U, Austin J, Oberlander TF. Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One. 2010;5:e12201.","journal-title":"PLoS One"},{"key":"667_CR43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4161\/epi.19551","volume":"7","author":"JW Schroeder","year":"2012","unstructured":"Schroeder JW, Smith AK, Brennan PA, Conneely KN, Kilaru V, Knight BT, et al. DNA methylation in neonates born to women receiving psychiatric care. Epigenetics. 2012;7:409\u201314.","journal-title":"Epigenetics"},{"key":"667_CR44","doi-asserted-by":"publisher","unstructured":"Sergi C, Caluseriu O, McColl H, Eisenstat DD. Hirschsprung\u2019s disease: clinical Dysmorphology, genes. Micro-RNAs Future Perspectives Pediatr Res. 2016; doi: 10.1038\/pr.2016.202 .","DOI":"10.1038\/pr.2016.202"},{"key":"667_CR45","doi-asserted-by":"publisher","unstructured":"Passarge E. Dissecting Hirschsprung disease. Nat Genet. 2002; doi: 10.1038\/ng878 .","DOI":"10.1038\/ng878"},{"issue":"417(2)","key":"667_CR46","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ydbio.2016.03.017","volume":"15","author":"RO Heuckeroth","year":"2016","unstructured":"Heuckeroth RO, Sch\u00e4fer K-H. Gene-environment interactions and the enteric nervous system: neural plasticity and Hirschsprung disease prevention. Dev Biol. 2016;15(417(2)):188\u201397.","journal-title":"Dev Biol"},{"key":"667_CR47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/humupd\/dmr022","volume":"17","author":"A Hackshaw","year":"2011","unstructured":"Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011;17:589\u2013604.","journal-title":"Hum Reprod Update"},{"key":"667_CR48","doi-asserted-by":"crossref","unstructured":"L\u00f6f Granstr\u00f6m A, Svenningsson A, Hagel E, Oddsberg J, Nordenskj\u00f6ld A, Wester T. Maternal risk factors and Perinatal characteristics for Hirschsprung disease. Pediatrics. 2016;138(1).","DOI":"10.1542\/peds.2015-4608"},{"key":"667_CR49","first-page":"631","volume":"137","author":"M Fu","year":"2010","unstructured":"Fu M, Sato Y, Lyons-Warren A, Zhang B, Kane MA, Napoli JL, et al. Vitamin a facilitates enteric nervous system precursor migration by reducing Pten accumulation. Dev Camb Engl. 2010;137:631\u201340.","journal-title":"Dev Camb Engl"},{"key":"667_CR50","doi-asserted-by":"publisher","unstructured":"Knudsen VK, Orozova-Bekkevold I, Rasmussen LB, Mikkelsen TB, Michaelsen KF, Olsen SF. Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? Public Health Nutr. 2004;7 doi: 10.1079\/PHN2004630 .","DOI":"10.1079\/PHN2004630"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0667-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T06:07:03Z","timestamp":1569478023000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0667-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0667-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2017,6,20]]},"article-number":"116"}}